Protara Therapeutics, Inc.: cash_and_equivalents
| Value | {"amount": 29971000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2020-06-30) |
| Status | current |
| Entity | Protara Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:59:58.519146+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bbcfde66-499d-4572-b5a9-5d70965d5919
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-21-040535 · Open the official SEC filing →Retrieved: 2026-08-19T12:59:58.519146+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001359931/cash-and-equivalents/2020-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bbcfde66-499d-4572-b5a9-5d70965d5919
History
- supersedes {"amount": 29970617, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} (evidence 0001213900-20-019642)